Breast Cancer and Fatigue

Sleep Medicine Clinics

Volumn 3, Issue 1, 2008, Pages 61-71

  Bardwell, Wayne A ^a   Ancoli Israel, Sonia ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIANEMIC AGENT; ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; CYTOKINE RECEPTOR ANTAGONIST; ERYTHROPOIETIN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; METHYLPHENIDATE; MODAFINIL; NEOPTERIN; PAROXETINE; PLACEBO; PSYCHOSTIMULANT AGENT; RECOMBINANT ERYTHROPOIETIN; TUMOR NECROSIS FACTOR RECEPTOR 2; VASCULOTROPIN;

ANEMIA; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CAUSAL ATTRIBUTION; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; FATIGUE; HUMAN; INFLAMMATION; INSOMNIA; PATHOGENESIS; PERSONALITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SCORING SYSTEM; SLEEP DISORDER; THROMBOEMBOLISM;

EID: 64749109983     PISSN: 1556407X     EISSN: 15564088     Source Type: Journal    
DOI: 10.1016/j.jsmc.2007.10.011     Document Type: Review

References (99)

1. Lawrence D.P., Kupelnick B., Miller K., et al. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr 32 (2004) 40-50
2. Curt G.A., Breitbart W., Cella D., et al. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5 (2000) 353-360
3. Ganz P.A., and Bower J.E. Cancer related fatigue: a focus on breast cancer and Hodgkin's disease survivors. Acta Oncol 46 (2007) 474-479
4. Ganz P.A., Moinpour C.M., Pauler D.K., et al. Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133. J Clin Oncol 21 (2003) 3512-3519
5. Ancoli-Israel S., Liu L., Marler M.R., et al. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer 14 (2006) 201-209
6. Bower J.E. Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav Immun 21 (2007) 863-871
7. Poulson M.J. Not just tired. J Clin Oncol 19 (2001) 4180-4181
8. Morrow G.R., Hickok J.T., Andrews P.L., et al. Reduction in serum cortisol after platinum based chemotherapy for cancer: a role for the HPA axis in treatment-related nausea?. Psychophysiology 39 (2002) 491-495
9. Morrow G.R., Andrews P.L., Hickok J.T., et al. Fatigue associated with cancer and its treatment. Support Care Cancer 10 (2002) 389-398
10. Ahlberg K., Ekman T., Gaston-Johansson F., et al. Assessment and management of cancer-related fatigue in adults. Lancet 362 (2003) 640-650
11. Carroll J.K., Kohli S., Mustian K.M., et al. Pharmacologic treatment of cancer-related fatigue. Oncologist 12 Suppl 1 (2007) 43-51
12. Armstrong T.S., Cohen M.Z., Eriksen L.R., et al. Symptom clusters in oncology patients and implications for symptom research in people with primary brain tumors. J Nurs Scholarsh 36 (2004) 197-206
13. Barton-Burke M. Cancer-related fatigue and sleep disturbances. Further research on the prevalence of these two symptoms in long-term cancer survivors can inform education, policy, and clinical practice. Am J Nurs 106 (2006) 72-77
14. Dodd M.J., Miaskowski C., and Lee K.A. Occurrence of symptom clusters. J Natl Cancer Inst Monogr 32 (2004) 76-78
15. Broeckel J.A., Jacobsen P.B., Horton J., et al. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 16 (1998) 1689-1696
16. Cella D., Davis K., Breitbart W., et al. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19 (2001) 3385-3391
17. Yellen S.B., Cella D.F., Webster K., et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13 (1997) 63-74
18. Vogelzang N.J., Breitbart W., Cella D., et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 34 (1997) 4-12
19. Patrick D.L., Ferketich S.L., Frame P.S., et al. National Institutes of Health State-of-the-Science Conference Statement: symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002. J Natl Cancer Inst 95 (2003) 1110-1117
20. Bower J.E., Ganz P.A., Desmond K.A., et al. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18 (2000) 743-753
21. Bower J.E., Ganz P.A., Desmond K.A., et al. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer 106 (2006) 751-758
22. Jacobsen P.B. Assessment of fatigue in cancer patients. J Natl Cancer Inst Monogr 32 (2004) 93-97
23. Ancoli-Israel S., Moore P.J., and Jones V. The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care (Engl) 10 (2001) 245-255
24. Bardwell W.A., Moore P., Ancoli-Israel S., et al. Fatigue in obstructive sleep apnea: driven by depressive symptoms instead of apnea severity?. Am J Psychiatry 160 (2003) 350-355
25. Cella D., Peterman A., Passik S., et al. Progress toward guidelines for the management of fatigue. Oncology (Williston Park) 12 (1998) 369-377
26. Andrykowski M.A., Schmidt J.E., Salsman J.M., et al. Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol 23 (2005) 6613-6622
27. Krupp L.B., LaRocca N.G., Muir-Nash J., et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46 (1989) 1121-1123
28. Ware J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). Med Care 30 (1992) 473-483
29. Ware J.E., Snow K.K., Kosinski M., et al. SF-36 health survey: manual and interpretation guide (2000), Quality-Metric Incorporated, Lincoln (RI)
30. Stein K.D., Martin S.C., Hann D.M., et al. A multidimensional measure of fatigue for use with cancer patients. Cancer Pract 6 (1998) 143-152
31. Stein K.D., Jacobsen P.B., Blanchard C.M., et al. Further validation of the multidimensional fatigue symptom inventory-short form. J Pain Symptom Manage 27 (2004) 14-23
32. Piper B.F., Dibble S.L., Dodd M.J., et al. The revised piper fatigue scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25 (1998) 677-684
33. McNair P.M., Lorr M., and Droppleman L.F. POMS manual: profile of mood states (1992), Educational and Industrial Testing Service, San Diego (CA)
34. Sadler I.J., and Jacobsen P.B. Progress in understanding fatigue associated with breast cancer treatment. Cancer Invest 19 (2001) 723-731
35. McCorkle R., and Quint-Benoliel J. Symptom distress, current concerns and mood disturbance after diagnosis of life-threatening disease. Soc Sci Med 17 (1983) 431-438
36. de Haes J.C., van Knippenberg F.C., and Neijt J.P. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 62 (1990) 1034-1038
37. Hann D.M., Jacobsen P.B., Azzarello L.M., et al. Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res 7 (1998) 301-310
38. Dimsdale J.E., ncoli-Israel S., Ayalon L., et al. Taking fatigue seriously, II: variability in fatigue levels in cancer patients. Psychosomatics 48 (2007) 247-252
39. Cimprich B. Pretreatment symptom distress in women newly diagnosed with breast cancer. Cancer Nurs 22 (1999) 185-194
40. Ancoli-Israel S., Liu L., Cooke J.R., et al. Women with breast cancer who experience fatigue, depression and poor sleep before chemotherapy have more fatigue and poorer quality of life during chemotherapy. Sleep Med 8 (2007) S50
41. Bower J.E. Prevalence and causes of fatigue after cancer treatment: the next generation of research. J Clin Oncol 23 (2005) 8280-8282
42. Irvine D., Vincent L., Graydon J.E., et al. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nurs 17 (1994) 367-378
43. Blesch K.S., Paice J.A., Wickham R., et al. Correlates of fatigue in people with breast or lung cancer. Oncol Nurs Forum 18 (1991) 81-87
44. Cella D. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34 (1997) 13-19
45. Cella D.F., Tulsky D.S., Gray G., et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11 (1993) 570-579
46. Meyerowitz B.E., Watkins I.K., and Sparks F.C. Quality of life for breast cancer patients receiving adjuvant chemotherapy. Am J Nurs 83 (1983) 232-235
47. Nail L.M., and Winningham M. Fatigue. In: Groenwald S.L., Frogge M.H., Goodman M., et al. (Eds). Cancer nursing: principles and practice (1993), Jones and Bartlett, Boston
48. Lindley C., Vasa S., Sawyer W.T., et al. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol 16 (1998) 1380-1387
49. Bower J.E., Ganz P.A., Aziz N., et al. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 64 (2002) 604-611
50. Berger A.M., and Higginbotham P. Correlates of fatigue during and following adjuvant breast cancer chemotherapy: a pilot study. Oncol Nurs Forum 27 (2000) 1443-1448
51. Cleeland C.S., Bennett G.J., Dantzer R., et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 97 (2003) 2919-2925
52. Lee B.N., Dantzer R., Langley K.E., et al. A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation 11 (2004) 279-292
53. Parker A.J., Wessely S., and Cleare A.J. The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol Med 31 (2001) 1331-1345
54. Payne J.K. A neuroendocrine-based regulatory fatigue model. Biol Res Nurs 6 (2004) 141-150
55. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition (1994), (DSM-IV) American Psychiatric Association Press, Washington, DC
56. Bardwell W.A., Ancoli-Israel S., and Dimsdale J.E. Comparison of the effects of depressive symptoms and apnea severity on fatigue in patients with obstructive sleep apnea: a replication study. J Affect Disord 97 (2007) 181-186
57. Andrykowski M.A., Curran S.L., and Lightner R. Off-treatment fatigue in breast cancer survivors: a controlled comparison. J Behav Med 21 (1998) 1-18
58. Jacobsen P.B., Donovan K.A., and Weitzner M.A. Distinguishing fatigue and depression in patients with cancer. Semin Clin Neuropsychiatry 8 (2003) 229-240
59. Goldstein D., Bennett B., Friedlander M., et al. Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC Cancer 6 (2006) 240
60. Smets E.M., Visser M.R., Willems-Groot A.F., et al. Fatigue and radiotherapy: (A) experience in patients undergoing treatment. Br J Cancer 78 (1998) 899-906
61. Bardwell W.A., Dimsdale J.E., and Pierce J.P. Risk factors for fatigue in women treated for early-stage breast cancer. [abstract]. Psychooncology 16 S1 (2007) 21-22
62. Savard J., and Morin C.M. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 19 (2001) 895-908
63. Davidson J.R., MacLean A.W., Brundage M.D., et al. Sleep disturbance in cancer patients. Soc Sci Med 54 (2002) 1309-1321
64. Liu L., and Ancoli-Israel S. Sleep disorders-clinical science. In: Cleeland C., Fischer D.G., and Dunn A. (Eds). Cancer symptom science (2007), Cambridge University Press, Cambridge (UK) [in press]
65. Fiorentino L., and Ancoli-Israel S. Sleep dysfunction in patients with cancer. Curr Treat Options Neurol 9 (2007) 337-346
66. Berger A.M., Parker K.P., Young-McCaughan S., et al. Sleep wake disturbances in people with cancer and their caregivers: state of the science. Oncol Nurs Forum 32 (2005) E98-E126
67. Liu L., Parker B., Dimsdale J., et al. Pre-treatment subjective sleep quality predicts fatigue, mood, and quality of life in breast cancer patients during chemotherapy. [abstract]. Sleep 29 Suppl (2006) A309
68. Ancoli-Israel S., Liu L., Parker B.A., et al. Sleep quality before treatment predicts fatigue, depression and quality of life in breast cancer patients during chemotherapy. Breast Cancer (2006) 100
69. Mills P.J., Parker B., Jones V., et al. The effects of standard anthracycline-based chemotherapy on soluble ICAM-1 and vascular endothelial growth factor levels in breast cancer. Clin Cancer Res 10 (2004) 4998-5003
70. Savard J., Simard S., Ivers H., et al. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part II: immunologic effects. J Clin Oncol 23 (2005) 6097-6106
71. Savard J., Davidson J.R., Ivers H., et al. The association between nocturnal hot flashes and sleep in breast cancer survivors. J Pain Symptom Manage 27 (2004) 513-522
72. Bardwell WA, Casden D, Rock CL, et al. The relative importance of specific risk factors for insomnia in women treated for early-stage breast cancer. Psycho-Oncology, in press.
73. Bardwell WA, Natarajan L, Dimsdale J, et al. Cancer-specific factors do not predict chronic insomnia in breast cancer survivors (BCS) [abstract]. Podium presentation for the 2007 Sleep Conference. Sleep, in press.
74. Mills P.J., Parker B., Dimsdale J.E., et al. The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer. Biol Psychol 69 (2005) 85-96
75. Schubert C., Hong S., Natarajan L., et al. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun 21 (2007) 413-427
76. Geinitz H., Zimmermann F.B., Stoll P., et al. Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. Int J Radiat Oncol Biol Phys 51 (2001) 691-698
77. Gelinas C., and Fillion L. Factors related to persistent fatigue following completion of breast cancer treatment. Oncol Nurs Forum 31 (2004) 269-278
78. Pusztai L., Mendoza T.R., Reuben J.M., et al. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine 25 (2004) 94-102
79. Smets E.M., Visser M.R., Willems-Groot A.F., et al. Fatigue and radiotherapy: (B) experience in patients 9 months following treatment. Br J Cancer 78 (1998) 907-912
80. Morrow G.R., Shelke A.R., Roscoe J.A., et al. Management of cancer-related fatigue. Cancer Invest 23 (2005) 229-239
81. Hanna A., Sledge G., Mayer M.L., et al. A phase II study of methylphenidate for the treatment of fatigue. Support Care Cancer 14 (2006) 210-215
82. Bruera E., Driver L., Barnes E.A., et al. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol 21 (2003) 4439-4443
83. Bruera E., Valero V., Driver L., et al. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 24 (2006) 2073-2078
84. Lower E., Fleischman S., Cooper A., et al. A phase III, randomized placebo-controlled trial of the safety and efficacy of d-MPH as a new treatment of fatigue and "chemobrain" in adult cancer patients. [abstract]. J Clin Oncol 23 16S (2005) 8000
85. Morrow G.R., Gillin J.C., Hickok J.T., et al. The positive effect of the psychostimulant modafinil on fatigue from cancer that persists after treatment is completed. [abstract]. J Clin Oncol 23 16S (2005) 8012
86. Kaleita T.A., Wellisch D., Grahan C.A., et al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. [abstract]. J Clin Oncol 23 16S (2005) 1503
87. Moss E.L., Simpson J.S., Pelletier G., et al. An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners. Psychooncology 15 (2006) 259-267
88. Cullum J.L., Wojciechowski A.E., Pelletier G., et al. Bupropion sustained release treatment reduces fatigue in cancer patients. Can J Psychiatry 49 (2004) 139-144
89. Morrow G.R., Hickok J.T., Roscoe J.A., et al. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol 21 (2003) 4635-4641
90. Roscoe J.A., Morrow G.R., Hickok J.T., et al. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 89 (2005) 243-249
91. Demetri G.D., Gabrilove J.L., Blasi M.V., et al. Benefits of epoetin alfa in anemic breast cancer patients receiving chemotherapy. Clin Breast Cancer 3 (2002) 45-51
92. Leyland-Jones B., Semiglazov V., Pawlicki M., et al. Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. J Clin Oncol 23 (2005) 5960-5972
93. Monk J.P., Phillips G., Waite R., et al. Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. J Clin Oncol 24 (2006) 1852-1859
94. Bower J.E. Management of cancer-related fatigue. Clin Adv Hematol Oncol 4 (2006) 828-829
95. Schneider C.M., Hsieh C.C., Sprod L.K., et al. Effects of supervised exercise training on cardiopulmonary function and fatigue in breast cancer survivors during and after treatment. Cancer 110 (2007) 918-925
96. Fiorentino L., and Ancoli-Israel S. Insomnia and its treatment in women with breast cancer. Sleep Med Rev 10 (2006) 419-429
97. Theobald D.E. Cancer pain, fatigue, distress, and insomnia in cancer patients. Clin Cornerstone 6 (2004) S15-S21
98. Collado-Hidalgo A., Bower J.E., Ganz P.A., et al. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 12 (2006) 2759-2766
99. Wratten C., Kilmurray J., Nash S., et al. Fatigue during breast radiotherapy and its relationship to biological factors. Int J Radiat Oncol Biol Phys 59 (2004) 160-167